bonyf Aktie
WKN DE: BONF01 / ISIN: BE6333353298
| 
30.06.2025 21:18:54
							 | 
					
Annual Results 2024
| 
 
bonyf NV
 / Key word(s): Annual Results/Financing
 
 
 
Dissemination of a Financial Wire News, transmitted by EQS Group.  | 
| Language: | English | 
| Issuer: | bonyf NV | 
| Kalvekeetdijk 179, box 105 | |
| 8300 Knokke-Heist | |
| Belgium | |
| Phone: | +41 79 412 42 79 | 
| E-mail: | president@bonyf.com | 
| Internet: | www.bonyf.com | 
| ISIN: | BE6333353298 | 
| EQS News ID: | 2162852 | 
| End of Announcement - EQS News Service | |
| 
 | 
2162852 30-Jun-2025 CET/CEST
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu bonyfmehr Nachrichten
| 
15.10.25 | 
							bonyf AG receives the EU-MDR Certification Class IIa for PerioCream (EQS Group) | |
| 
15.09.25 | 
							bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf (EQS Group) | |
| 
05.09.25 | 
							bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments (EQS Group) | |
| 
11.08.25 | 
							Periocream: The Future Commercial Winner for bonyf (EQS Group) | |
| 
14.07.25 | 
							bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility (EQS Group) | |
| 
30.06.25 | 
							Annual Results 2024 (EQS Group) | |
| 
03.06.25 | 
							bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India (EQS Group) | |
| 
15.05.25 | 
							bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy (EQS Group) | 
Analysen zu bonyfmehr Analysen
Aktien in diesem Artikel
| bonyf | 12,90 | 22,86% | 
									 |